Study Assessing the Effect of 3-week Treatment With One of Three Oral Doses of Quinagolide

Clinical trial NCT00329693 · COMPLETED

Trial details

NCT number: NCT00329693
Sponsor: Ferring Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Hyperstimulation Syndrome

Start date: 2006-06-01
Primary completion: 2007-08-01
Enrollment: 182

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.